tiprankstipranks
The Fly

Avadel Pharmaceuticals sees Q4 revenue $50M, consensus $52.7M

Avadel Pharmaceuticals sees Q4 revenue $50M, consensus $52.7M

The company said, “Fourth quarter revenue was impacted by approximately $6.0 million due to an estimated 1.5 fewer weeks of inventory in the channel at December 31, 2024, compared to September 30, 2024.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com